Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 119 +2.50 (+2.15%)
As of 07/11/2025 11:49 AM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
113
120
50-Day Range
112.50
140
52-Week Range
106
151
Volume
12,197 shs
Average Volume
125,377 shs
Market Capitalization
£100.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 168.33
Consensus Rating
Buy

Company Overview

Diaceutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

DXRX MarketRank™: 

Diaceutics scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Diaceutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Diaceutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Diaceutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Diaceutics is -35.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Diaceutics is -35.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Diaceutics has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for DXRX.
  • Dividend Yield

    Diaceutics does not currently pay a dividend.

  • Dividend Growth

    Diaceutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for DXRX.
  • News Sentiment

    Diaceutics has a news sentiment score of -0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Diaceutics this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Diaceutics insiders have sold 420,068.07% more of their company's stock than they have bought. Specifically, they have bought £149.94 in company stock and sold £630,000 in company stock.

  • Percentage Held by Insiders

    34.30% of the stock of Diaceutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.38% of the stock of Diaceutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Diaceutics' insider trading history.
Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

Royal Bank Of Canada Cuts Diaceutics (LON:DXRX) Price Target to GBX 185
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 at the beginning of 2025. Since then, DXRX stock has decreased by 3.3% and is now trading at GBX 119.

Diaceutics PLC (LON:DXRX) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($2.02) earnings per share for the quarter. Diaceutics had a negative net margin of 10.90% and a negative trailing twelve-month return on equity of 7.15%.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
5/13/2025
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 185
Low Price Target
GBX 160
Potential Upside/Downside
+41.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (3.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
117.73
P/E Growth
N/A
Net Income
-£2.84 million
Net Margins
-10.90%
Pretax Margin
N/A
Return on Equity
-7.15%
Return on Assets
-6.06%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
4.85
Quick Ratio
9.92

Sales & Book Value

Annual Sales
£26.08 million
Price / Sales
3.85
Cash Flow
GBX 38.14 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
2.59

Miscellaneous

Outstanding Shares
84,393,829
Free Float
N/A
Market Cap
£100.43 million
Optionable
Not Optionable
Beta
0.58
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:DXRX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners